Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database.
Zhong-Li DuYang WangDing-Yuan WangLi ZhangZhi-Min BianYing DengCheng-Shan XuDong-Cai LinLi XieYao JiaJi-Dong GaoBai-Lin ZhangPublished in: Breast cancer research and treatment (2020)
According to current clinical guidelines, patients with stage T1bN0M0 TNBC are probably overtreated. The prognosis of these patients with stage T1aN0M0 or T1bN0M0 disease is good enough that adjuvant chemotherapy cannot improve it further.
Keyphrases